ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2020
Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report.
Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.
- Adult cardiovascular surgery and the coronavirus disease 2019 (COVID-19) pandemic: the Italian experience.Interactive cardiovascular and thoracic surgery · 2020Pooled it
- Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis.Transplantation proceedings · 2020Pooled it
- ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up.Cardiovascular research · 2022Review
- ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up.European heart journal · 2022Review
- Management of post cardiac transplantation immunosuppression and COVID-19: A case report.Annals of medicine and surgery (2012) · 2021Article
- Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes.Best practice & research. Clinical anaesthesiology · 2021Review
- Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic.Transplantation direct · 2021Article
- COVID-19 Risk Mapping with Considering Socio-Economic Criteria Using Machine Learning Algorithms.International journal of environmental research and public health · 2021Article
- COVID-19-related myocarditis post-heart transplantation.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021Article
- Article
- How the Heart Was Involved in COVID-19 during the First Pandemic Phase: A Review.Epidemiologia (Basel, Switzerland) · 2021Review
- Potential Effects of Coronaviruses on the Liver: An Update.Frontiers in medicine · 2021Review
- Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2021Review
- Heart failure and COVID-19.Heart failure reviews · 2021Review
- COVID-19 and Cardiovascular Diseases.Advances in experimental medicine and biology · 2021Article
- Varying presentations of COVID-19 in young heart transplant recipients: A case series.Pediatric transplantation · 2020Article
- Heart transplantation during the COVID-19 pandemic: follow-up organization and characteristics of infected patients.Revista espanola de cardiologia (English ed.) · 2020Article
- [Heart transplant during the COVID-19 pandemic: follow-up organization and characteristics of infected patients].Revista espanola de cardiologia · 2020Article
- Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2020Article
- Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
14 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe epidemiologic and clinical characteristics of heart transplant (HTx) recipients during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic remains unclear. We studied the characteristics of HTx recipients from December 20, 2019, to February 25, 2020, in an effort to understand their risk and outcomes.
methodsAll accessible HTx recipients were included in this single-center retrospective study. We collected information on the recipients using a web-based questionnaire as well as the hospital database.
resultsWe followed 87 HTx recipients (72.4% were men, and the average age was 51 years). A total of 79 recipients resided in Hubei, and 57 recipients had a Wuhan-related history of travel or contact. Most took precautionary measures while in contact with suspicious crowds, and 96.6% of the families and communities undertook prevention and quarantine procedures. Four upper airway infections were reported, and 3 of them tested negative for SARS-CoV-2 (the fourth recovered and was not tested). All cases were mild and successfully recovered after proper treatment. Laboratory results of 47 HTx cases within the last 2 months were extracted. Of these, 21.3% of recipients had pre-existing lymphopenia, and 87.2% of recipients had a therapeutic concentration of tacrolimus (5-12 ng/ml). Liver and kidney insufficiency was seen in 5 and 6 recipients, respectively.
conclusionHTx recipients who practiced appropriate prevention measures had a low rate of infection with SARS-CoV-2 and transition to the associated disease COVID-19. These early data will require confirmation as the pandemic establishes around the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.